Market Research Logo

Human Papillomavirus Testing Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

Human Papillomavirus Testing Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

The report on global human papillomavirus testing market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global human papillomavirus testing market to grow with a CAGR of 15.2% over the forecast period of 2018-2024. The study on human papillomavirus testing market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

A viral infection that is passed between people through skin-to-skin contact is known as Human papillomavirus (HPV). According to the Centers for Disease Control and Prevention (CDC), HPV is the most common sexually transmitted infection that affects both men and women. Cervix cell changes is caused by human papillomavirus. The HPV test checks for the virus, not cell changes.

The growing prevalence of cervical cancer and early detection to prevent this infection is likely to drive the growth of this market in the coming years. Additionally, rising incidences of vaginal cancer, increased adoption of screening tests, the increasing number of awareness programs by government and private organizations, and technologically advancement are some of the factors that are likely to boost the growth of the market.

Among the geographies, North America is expected to be largest market for HPV testing followed by Europe due to government initiatives in various countries such as the US, Canada, in this region. While, Asia-Pacific is expected to grow fast during the forecast period, owing to the increasing awareness about this infection, and growing government support in countries like China and India is likely to augment the growth in this region.

The rising competition among test kit manufacturing companies will increase the competitive environment in the market. For instance, Becton Dickinson and Company (BD) received the FDA clearance for the fully automated cervical cancer screening system, in 2016. This automated system reduces human interference as well as the cost and, thus increasing overall workflow efficiency.

The report on human papillomavirus testing market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global human papillomavirus testing market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global human papillomavirus testing market over the period of 2016 to 2024. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global human papillomavirus testing market is segmented on the basis of product and end-user.

Global Human Papillomavirus Testing Market by Product
Consumables
Systems

Global Human Papillomavirus Testing Market by End-User
Hospitals
Physicians' Office Laboratories
Clinical Diagnostic Laboratories

Company Profiles
Cepheid
Abbott Laboratories
Arbor Vita
Roche Diagnostics
Genera Biosystems
Breakspear Medical
IncellDx
Delphi Bioscience
Fujirebio Diagnostics
OralDNA Labs

How this report delivers?
1. Comprehensive analysis of global as well as regional markets of human papillomavirus testing market.
2. Complete coverage of all the segments in human papillomavirus testing market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global human papillomavirus testing market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Human Papillomavirus Testing Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.5. Competitive Landscape in the Global Human Papillomavirus Testing Market
4. Global Human Papillomavirus Testing Market by Product
4.1. Consumables
4.2. Systems
5. Global Human Papillomavirus Testing Market by End-User
5.1. Hospitals
5.2. Physicians' Office Laboratories
5.3. Clinical Diagnostic Laboratories
6. Global Human Papillomavirus Testing Market by Region 2018-2024
6.1. North America
6.1.1.1. North America Human Papillomavirus Testing Market by Product
6.1.1.2. North America Human Papillomavirus Testing Market by End-user
6.1.1.3. North America Human Papillomavirus Testing Market by Country
6.2. Europe
6.2.1.1. Europe Human Papillomavirus Testing Market by Product
6.2.1.2. Europe Human Papillomavirus Testing Market by End-user
6.2.1.3. Europe Human Papillomavirus Testing Market by Country
6.3. Asia-Pacific
6.3.1.1. Asia-Pacific Human Papillomavirus Testing Market by Product
6.3.1.2. Asia-Pacific Human Papillomavirus Testing Market by End-user
6.3.1.3. Asia-Pacific Human Papillomavirus Testing Market by Country
6.4. RoW
6.4.1.1. RoW Human Papillomavirus Testing Market by Product
6.4.1.2. RoW Human Papillomavirus Testing Market by End-user
6.4.1.3. RoW Human Papillomavirus Testing Market by Sub-region
7. Company Covered
7.1. Cepheid
7.2. Abbott Laboratories
7.3. Arbor Vita
7.4. Roche Diagnostics
7.5. Genera Biosystems
7.6. Breakspear Medical
7.7. Incelldx
7.8. Delphi Bioscience
7.9. Fujirebio Diagnostics
7.10.Oraldna Labs

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report